These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 29800697)
1. Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines? Khademi F; Taheri RA; Yousefi Avarvand A; Vaez H; Momtazi-Borojeni AA; Soleimanpour S Microb Pathog; 2018 Aug; 121():218-223. PubMed ID: 29800697 [TBL] [Abstract][Full Text] [Related]
2. Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost? Khademi F; Derakhshan M; Yousefi-Avarvand A; Tafaghodi M; Soleimanpour S Expert Rev Vaccines; 2018 Jan; 17(1):31-44. PubMed ID: 29148853 [TBL] [Abstract][Full Text] [Related]
3. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates. Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520 [TBL] [Abstract][Full Text] [Related]
4. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy. Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020 [TBL] [Abstract][Full Text] [Related]
5. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice. Li W; Li M; Deng G; Zhao L; Liu X; Wang Y Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477 [TBL] [Abstract][Full Text] [Related]
6. Mucosal Delivery of Fusion Proteins with Copland A; Diogo GR; Hart P; Harris S; Tran AC; Paul MJ; Singh M; Cutting SM; Reljic R Front Immunol; 2018; 9():346. PubMed ID: 29593708 [TBL] [Abstract][Full Text] [Related]
7. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B. Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900 [TBL] [Abstract][Full Text] [Related]
8. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge. Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809 [TBL] [Abstract][Full Text] [Related]
9. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
10. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine. Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321 [TBL] [Abstract][Full Text] [Related]
11. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736 [TBL] [Abstract][Full Text] [Related]
12. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
13. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592 [TBL] [Abstract][Full Text] [Related]
14. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines. Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609 [TBL] [Abstract][Full Text] [Related]
15. Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose. Zhang M; Dong C; Xiong S Front Cell Infect Microbiol; 2017; 7():34. PubMed ID: 28224119 [TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of Th1-Type Immune Responses to Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214 [TBL] [Abstract][Full Text] [Related]
18. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865 [TBL] [Abstract][Full Text] [Related]
20. Intranasal bovine β-defensin-5 enhances antituberculosis immunity in a mouse model by a novel protein-based respiratory mucosal vaccine. Liang Z; Li H; Qu M; Liu Y; Wang Y; Wang H; Dong Y; Chen Y; Ge X; Zhou X Virulence; 2022 Dec; 13(1):949-962. PubMed ID: 35603910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]